- CA$46.13m
- CA$105.30m
- CA$23.81m
- 91
- 96
- 47
- 92
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.5 | 5.17 | 10.2 | 6.45 | 23.8 |
Cost of Revenue | |||||
Gross Profit | 3.82 | 2.66 | 4.17 | 3.43 | 9.9 |
Selling / General / Administrative Expenses | |||||
Total Operating Expenses | 5 | -1.59 | 0.465 | -5.94 | 14.1 |
Operating Profit | 5.46 | 6.76 | 9.69 | 12.4 | 9.69 |
Net Income Before Taxes | 5.46 | 6.76 | 9.69 | 12.4 | 9.69 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.69 | 6.51 | 8 | 10.7 | 7.58 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 4.86 | 6.51 | 8 | 10.3 | 7.34 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 4.86 | 6.51 | 8 | 10.3 | 7.34 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.092 | 0.12 | 0.143 | 0.178 | 0.125 |
Dividends per Share |